A detailed history of Ieq Capital, LLC transactions in Personalis, Inc. stock. As of the latest transaction made, Ieq Capital, LLC holds 22,000 shares of PSNL stock, worth $126,500. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,000
Previous 22,000 -0.0%
Holding current value
$126,500
Previous $25,000 372.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 31, 2022

SELL
$12.24 - $21.25 $293 - $510
-24 Reduced 0.11%
22,000 $314,000
Q3 2021

Nov 09, 2021

BUY
$16.69 - $26.05 $367,580 - $573,725
22,024 New
22,024 $423,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $264M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Ieq Capital, LLC Portfolio

Follow Ieq Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ieq Capital, LLC with notifications on news.